{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:55:50Z","timestamp":1794009350118,"version":"4.8.0"},"reference-count":92,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The gut microbiota contributes to host physiological homeostasis through the production of diverse bioactive metabolites that orchestrate immune responses, maintain intestinal barrier integrity, and regulate metabolic signaling. Increasing evidence indicates that these microbiota-derived metabolites act as critical mediators linking microbial composition to gastrointestinal tumorigenesis. Among them, short-chain fatty acids (SCFAs), bile acids, and amino acid-derived metabolites\u2014particularly tryptophan metabolites\u2014have been most extensively studied. These metabolites influence tumor initiation and progression via multiple mechanisms, including modulation of inflammatory responses, epigenetic remodeling, control of cell proliferation and apoptosis, and reprogramming of the tumor microenvironment (TME). This review provides a systematic overview of the sources, biological functions, and mechanistic roles of major gut microbial metabolites in gastrointestinal cancer. We emphasize three interconnected regulatory axes: inflammation\u2013immunity modulation, intestinal barrier homeostasis, and metabolism\u2013epigenetic reprogramming, while highlighting the tryptophan\u2013aryl hydrocarbon receptor (AhR) axis as a central immunoregulatory hub. SCFAs generally exert protective effects by reinforcing epithelial barrier function and supporting anti-tumor immunity, whereas bile acids display context-dependent duality, with secondary bile acids being closely associated with chronic inflammation, DNA damage, and colorectal cancer progression. Tryptophan metabolites primarily shape mucosal immunity and tumor immune escape through activation of AhR signaling. Despite substantial progress, important challenges remain, including incomplete causal understanding, marked inter-individual variability, and limited clinical translation. Future studies integrating multi-omics approaches, single-cell and spatial technologies, and prospective clinical validation will be essential for defining key metabolite networks and advancing metabolite-based biomarkers and precision therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1862232","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:35:08Z","timestamp":1783575308000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Gut microbiota-derived metabolites in gastrointestinal cancer: immunomodulatory mechanisms via the tryptophan\u2013AhR axis and translational perspectives"],"prefix":"10.3389","volume":"17","author":[{"given":"Xue","family":"Xing","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ying","sequence":"additional","affiliation":[{"name":"College of Laboratory Medicine, Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Xia","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, The Second Affiliated Hospital of Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.37201\/req\/056.2024","article-title":"Human intestinal microbiome: role in health and disease","volume":"37","author":"Cant\u00f3n","year":"2024","journal-title":"Rev Esp Quimioter"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"de Vos","year":"2022","journal-title":"Gut"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10482-020-01474-7","article-title":"Human gut microbiota\/microbiome in health and diseases: a review","volume":"113","author":"Gomaa","year":"2020","journal-title":"Antonie van Leeuwenhoek"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02521-5","article-title":"Gut microbial metabolites in cancer immunomodulation","volume":"25","author":"Liu","year":"2025","journal-title":"Mol Cancer"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1710880","article-title":"Gut microbiota-derived metabolites in immunomodulation and gastrointestinal cancer immunotherapy","volume":"16","author":"Luo","year":"2025","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1186\/s12885-021-09054-2","article-title":"Gut microbiome and its role in colorectal cancer","volume":"21","author":"Rebersek","year":"2021","journal-title":"BMC Cancer"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202207366","article-title":"A review of gut microbiota-derived metabolites in tumor progression and cancer therapy","volume":"10","author":"Yang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.seminoncol.2025.152398","article-title":"The effects of microbiota-derived short-chain fatty acids on T lymphocytes: from autoimmune diseases to cancer","volume":"52","author":"Saadh","year":"2025","journal-title":"Semin Oncol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32563","article-title":"The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: an old story, yet mesmerizing","volume":"146","author":"Liu","year":"2020","journal-title":"Int J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-021-03729-w","article-title":"Gut microbiota-derived metabolites in CRC progression and causation","volume":"147","author":"Dalal","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2019.1598334","article-title":"Tryptophan (Trp) modulates gut homeostasis via aryl hydrocarbon receptor (AhR)","volume":"60","author":"Sun","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1190810","article-title":"Short chain fatty acids prime colorectal cancer cells to activate antitumor immunity","volume":"14","author":"Mowat","year":"2023","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2377576","article-title":"Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation","volume":"16","author":"Li","year":"2024","journal-title":"Gut Microbes"},{"key":"B15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35183","article-title":"Circulating tryptophan-kynurenine pathway metabolites are associated with all-cause mortality among patients with stage I-III colorectal cancer","volume":"156","author":"Damerell","year":"2025","journal-title":"Int J Cancer"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-017-0219-5","article-title":"Influence of bile acids on colorectal cancer risk: potential mechanisms mediated by diet - gut microbiota interactions","volume":"6","author":"Ocvirk","year":"2017","journal-title":"Curr Nutr Rep"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/08830185.2021.1954638","article-title":"Tryptophan metabolites modulate inflammatory bowel disease and colorectal cancer by affecting immune system","volume":"41","author":"Ala","year":"2022","journal-title":"Int Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/febs.16245","article-title":"Tryptophan and its metabolites in normal physiology and cancer etiology","volume":"290","author":"Perez-Castro","year":"2023","journal-title":"FEBS J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-023-10117-y","article-title":"Short-chain fatty acids in cancer pathogenesis","volume":"42","author":"Feitelson","year":"2023","journal-title":"Cancer Metastasis Rev"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186892","article-title":"Regulation of short-chain fatty acids in the immune system","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/med.21752","article-title":"Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: a therapeutic target to control intestinal inflammation","volume":"41","author":"Zhang","year":"2021","journal-title":"Med Res Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/nu13041189","article-title":"Targeting dietary and microbial tryptophan-indole metabolism as therapeutic approaches to colon cancer","volume":"13","author":"Wyatt","year":"2021","journal-title":"Nutrients"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.11.003","article-title":"Short-chain fatty acids and cancer","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","article-title":"Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T cell effector functions","volume":"57","author":"Cong","year":"2024","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1603658","article-title":"Microbial metabolite-driven immune reprogramming in tumor immunotherapy: mechanisms and therapeutic perspectives","volume":"16","author":"Lu","year":"2025","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.cmet.2021.03.002","article-title":"Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8(+) T cell immunity","volume":"33","author":"He","year":"2021","journal-title":"Cell Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051588","article-title":"The impact of gut microbiota-derived metabolites on the tumor immune microenvironment","volume":"15","author":"Luu","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1456030","article-title":"Metabolic mediators: microbial-derived metabolites as key regulators of anti-tumor immunity, immunotherapy, and chemotherapy","volume":"15","author":"Lu","year":"2024","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115345","article-title":"Targeting bacterial metabolites in tumor for cancer therapy: an alternative approach for targeting tumor-associated bacteria","volume":"211","author":"Ji","year":"2024","journal-title":"Adv Drug Delivery Rev"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2021.05.018","article-title":"Blockade of IDO-Kynurenine-AhR axis ameliorated colitis-associated colon cancer via inhibiting immune tolerance","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"key":"B35","article-title":"Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions","volume":"59","author":"Tazoe","year":"2008","journal-title":"J Physiol Pharmacol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01434","article-title":"Implication of G protein-coupled receptor 43 in intestinal inflammation: a mini-review","volume":"9","author":"Yang","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2013.04.056","article-title":"Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice","volume":"145","author":"Kim","year":"2013","journal-title":"Gastroenterology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-020-01947-2","article-title":"SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1\u03b1","volume":"98","author":"Zhou","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1159\/000492853","article-title":"Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy","volume":"49","author":"Feng","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.813745","article-title":"Secondary bile acids and tumorigenesis in colorectal cancer","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.5672","article-title":"The role of the gut microbiota in bile acid metabolism","volume":"16","author":"Ram\u00edrez-P\u00e9rez","year":"2017","journal-title":"Ann Hepatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of gut microbiota with bile acid metabolism and its influence on disease states","volume":"101","author":"Staley","year":"2017","journal-title":"Appl Microbiol Biotechnol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2025.1611698","article-title":"Metabolic interactions: how gut microbial metabolites influence colorectal cancer","volume":"16","author":"Cao","year":"2025","journal-title":"Front Microbiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115206","article-title":"Tumor-induced metabolic immunosuppression: mechanisms and therapeutic targets","volume":"44","author":"Ricci","year":"2025","journal-title":"Cell Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28436","article-title":"Role of SCFAs in gut microbiome and glycolysis for colorectal cancer therapy","volume":"234","author":"Wang","year":"2019","journal-title":"J Cell Physiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111227","article-title":"Sodium butyrate blocks the growth of colorectal cancer by inhibiting the aerobic glycolysis mediated by SIRT4\/HIF-1\u03b1","volume":"403","author":"Zhang","year":"2024","journal-title":"Chem Biol Interact"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1074\/jbc.RA117.000631","article-title":"Trace derivatives of kynurenine potently activate the aryl hydrocarbon receptor (AHR)","volume":"293","author":"Seok","year":"2018","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","article-title":"Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer","volume":"12","author":"Luu","year":"2021","journal-title":"Nat Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov"},{"key":"B54","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cei\/uxab028","article-title":"The effect of short-chain fatty acids on M2 macrophages polarization in vitro and in vivo","volume":"207","author":"Huang","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.MCHD-0028-2016","article-title":"G protein-coupled receptors in macrophages","volume":"4","author":"Lin","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00277","article-title":"Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases","volume":"10","author":"Parada Venegas","year":"2019","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.108517","article-title":"SCFAs switch stem cell fate through HDAC inhibition to improve barrier integrity in 3D intestinal organoids from patients with obesity","volume":"26","author":"Farhadipour","year":"2023","journal-title":"iScience"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2741\/s303","article-title":"Modulation of cell cycle regulators by HDACs","volume":"4","author":"Telles","year":"2012","journal-title":"Front Biosci (Schol Ed)"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2023.0394","article-title":"Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma","volume":"21","author":"Song","year":"2023","journal-title":"Cancer Biol Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.04.029","article-title":"Farnesoid X receptor (FXR): Structures and ligands","volume":"19","author":"Jiang","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1865-0","article-title":"Microbial bile acid metabolites modulate gut ROR\u03b3(+) regulatory T cell homeostasis","volume":"577","author":"Song","year":"2020","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-022-12011-z","article-title":"Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment","volume":"106","author":"Zhu","year":"2022","journal-title":"Appl Microbiol Biotechnol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3892\/ijmm.6.6.699","article-title":"Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis","volume":"6","author":"Tateda","year":"2000","journal-title":"Int J Mol Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.15096","article-title":"The role of microbiota in esophageal squamous cell carcinoma: a review of the literature","volume":"14","author":"Chiang","year":"2023","journal-title":"Thorac Cancer"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6484","article-title":"The tryptophan-kynurenine pathway in immunomodulation and cancer metastasis","volume":"12","author":"Basson","year":"2023","journal-title":"Cancer Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2017.11.007","article-title":"Targeting the IDO1\/TDO2-KYN-AhR pathway for cancer immunotherapy - challenges and opportunities","volume":"39","author":"Cheong","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"B69","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2017.12.012","article-title":"Regulation of the immune response by the aryl hydrocarbon receptor","volume":"48","author":"Guti\u00e9rrez-V\u00e1zquez","year":"2018","journal-title":"Immunity"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-18-2882","article-title":"Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan-kynurenine-aryl hydrocarbon axis","volume":"25","author":"Labadie","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094644","article-title":"Tryptophan metabolites at the crossroad of immune-cell interaction via the aryl hydrocarbon receptor: implications for tumor immunotherapy","volume":"22","author":"Gargaro","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.807271","article-title":"Targeting tryptophan catabolism in cancer immunotherapy era: challenges and perspectives","volume":"13","author":"Peyraud","year":"2022","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0702-0","article-title":"Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond","volume":"41","author":"Muller","year":"2019","journal-title":"Semin Immunopathol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00513-x","article-title":"Targeting the gut microbiota for cancer therapy","volume":"22","author":"Fernandes","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-061124-102218","article-title":"Gut microbiota-related biomarkers in immuno-oncology","volume":"65","author":"Silva","year":"2025","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12672-024-01480-5","article-title":"Unveiling the immune effects of AHR in tumors: a decade of insights from bibliometric analysis (2010-2023)","volume":"15","author":"Xie","year":"2024","journal-title":"Discov Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41573-025-01211-7","article-title":"The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development","volume":"24","author":"Elkrief","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217123","article-title":"The gut microbiota improves the efficacy of immune-checkpoint inhibitor immunotherapy against tumors: from association to cause and effect","volume":"598","author":"Xia","year":"2024","journal-title":"Cancer Lett"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1410928","article-title":"The role of the gut microbiota in tumor, immunity, and immunotherapy","volume":"15","author":"Xie","year":"2024","journal-title":"Front Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100773","article-title":"Microbiota-derived metabolites: key modulators of cancer immunotherapies","volume":"6","author":"Perl","year":"2025","journal-title":"Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v17.i7.107110","article-title":"Multi-omics perspectives for gastrointestinal Malignancy: a systematic review","volume":"17","author":"Koo","year":"2025","journal-title":"World J Gastrointest Surg"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3390\/cells14221779","article-title":"The gut microbiome as a biomarker and therapeutic target of immune checkpoint inhibitors: a review for oncologists","volume":"14","author":"Susiriwatananont","year":"2025","journal-title":"Cells"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3390\/medicina61091595","article-title":"Clinical evidence for microbiome-based strategies in cancer immunotherapy: a state-of-the-art review","volume":"61","author":"Petrelli","year":"2025","journal-title":"Med (Kaunas)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13099-025-00734-z","article-title":"Gut microbiome in gastrointestinal neoplasms: from mechanisms to precision therapeutic strategies","volume":"17","author":"Song","year":"2025","journal-title":"Gut Pathog"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000002573","article-title":"Colorectal cancer: the immune microenvironment and the gut microbiota - new perspectives, challenges, and opportunities","volume":"111","author":"Zhou","year":"2025","journal-title":"Int J Surg"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1163\/18762891-bja00026","article-title":"A systematic review of the gut microbiome, metabolites, and multi-omics biomarkers across the colorectal cancer care continuum","volume":"15","author":"Wu","year":"2024","journal-title":"Benef Microbes"},{"key":"B88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12967-024-04984-4","article-title":"Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer","volume":"22","author":"Zou","year":"2024","journal-title":"J Transl Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12943-024-02113-9","article-title":"Spatiotemporal metabolomic approaches to the cancer-immunity panorama: a methodological perspective","volume":"23","author":"Xiao","year":"2024","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1053\/j.gastro.2025.02.035","article-title":"Machine learning and artificial intelligence in the multi-omics approach to gut microbiota","volume":"169","author":"Rozera","year":"2025","journal-title":"Gastroenterology"},{"key":"B91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.immuni.2023.12.009","article-title":"Nutritional regulation of microbiota-derived metabolites: implications for immunity and inflammation","volume":"57","author":"Arifuzzaman","year":"2024","journal-title":"Immunity"},{"key":"B92","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12964-024-01552-7","article-title":"Tryptophan metabolism in digestive system tumors: unraveling the pathways and implications","volume":"22","author":"Yu","year":"2024","journal-title":"Cell Commun Signal"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1862232\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:35:09Z","timestamp":1783575309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1862232\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":92,"alternative-id":["10.3389\/fimmu.2026.1862232"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1862232","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1862232"}}